Cargando…

Exploring the past, present, and future of postoperative radiotherapy for N2 stage non-small cell lung cancer

Despite conventionally applied postoperative radiotherapy (PORT) in pathological N2 (pN2) stage non-small cell lung cancer (NSCLC) considering high locoregional recurrence, its survival benefit has been a continuous topic of debate. Although several randomized clinical trials have been conducted, ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Byoung Hyuck, Kim, Jae Sik, Kim, Hak Jae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Radiation Oncology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10556840/
https://www.ncbi.nlm.nih.gov/pubmed/37793623
http://dx.doi.org/10.3857/roj.2023.00430

Ejemplares similares